{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "North Wales",
      "address_1": "1090 Horsham Rd",
      "reason_for_recall": "Failed Dissolution Specifications",
      "address_2": "",
      "product_quantity": "6,800 cartons",
      "code_info": "Lot # 34027040A; Exp 10/17",
      "center_classification_date": "20170113",
      "distribution_pattern": "Nationwide in the USA and Puerto Rico",
      "state": "PA",
      "product_description": "Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA  19454.",
      "report_date": "20170125",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Teva Pharmaceuticals USA",
      "recall_number": "D-0431-2017",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "75872",
      "termination_date": "20170629",
      "more_code_info": "",
      "recall_initiation_date": "20161201",
      "postal_code": "19454-1505",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}